AU5556799A - Assay for assembly of herpes simplex virus capsid - Google Patents
Assay for assembly of herpes simplex virus capsidInfo
- Publication number
- AU5556799A AU5556799A AU55567/99A AU5556799A AU5556799A AU 5556799 A AU5556799 A AU 5556799A AU 55567/99 A AU55567/99 A AU 55567/99A AU 5556799 A AU5556799 A AU 5556799A AU 5556799 A AU5556799 A AU 5556799A
- Authority
- AU
- Australia
- Prior art keywords
- assay
- assembly
- herpes simplex
- simplex virus
- virus capsid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5184—Virus capsids or envelopes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
- G01N2333/035—Herpes simplex virus I or II
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9633898P | 1998-08-12 | 1998-08-12 | |
US60096338 | 1998-08-12 | ||
PCT/US1999/018277 WO2000009158A1 (en) | 1998-08-12 | 1999-08-12 | Assay for assembly of herpes simplex virus capsid |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5556799A true AU5556799A (en) | 2000-03-06 |
Family
ID=22256900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55567/99A Abandoned AU5556799A (en) | 1998-08-12 | 1999-08-12 | Assay for assembly of herpes simplex virus capsid |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5556799A (en) |
WO (1) | WO2000009158A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258932B1 (en) * | 1999-08-09 | 2001-07-10 | Tripep Ab | Peptides that block viral infectivity and methods of use thereof |
US6593455B2 (en) | 2001-08-24 | 2003-07-15 | Tripep Ab | Tripeptide amides that block viral infectivity and methods of use thereof |
WO2003024995A1 (en) | 2001-09-19 | 2003-03-27 | Tripep Ab | Molecules that block viral infectivity and methods of use thereof |
JP2005533111A (en) | 2002-07-12 | 2005-11-04 | アメリカ合衆国 | Assay for construction of Ebola virus nucleocapsid |
DE10300109A1 (en) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Method for inhibiting replication of herpes viruses |
AU2005287383B2 (en) * | 2004-05-25 | 2011-09-22 | Chimeros, Inc. | Self-assembling nanoparticle drug delivery system |
WO2008108776A1 (en) | 2006-04-07 | 2008-09-12 | Chimeros, Inc. | Compositions and methods for treating b- cell malignancies |
WO2010120874A2 (en) | 2009-04-14 | 2010-10-21 | Chimeros, Inc. | Chimeric therapeutics, compositions, and methods for using same |
JP2014527072A (en) | 2011-09-09 | 2014-10-09 | バイオメド リアルティー, エル.ピー. | Methods and compositions for controlling the assembly of viral proteins |
-
1999
- 1999-08-12 AU AU55567/99A patent/AU5556799A/en not_active Abandoned
- 1999-08-12 WO PCT/US1999/018277 patent/WO2000009158A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000009158A1 (en) | 2000-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9755698A (en) | Cyclone separator | |
AU9755898A (en) | Cyclone separator | |
AU9575398A (en) | Spillproof microplate assembly | |
AU8145898A (en) | Anti-pollution system | |
AU8694898A (en) | Targeted gene discovery | |
AU6111000A (en) | Inhibitors of viral helcase | |
AU5556799A (en) | Assay for assembly of herpes simplex virus capsid | |
AUPP967999A0 (en) | Viral variants | |
AU3900893A (en) | Quantitative viral assay | |
AU2587795A (en) | Epstein-barr virus transcription factor binding assay | |
AU2001282986A1 (en) | The protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp10pk) has anti-apoptopic activity | |
AU7589598A (en) | Elevation of hdl cholesterol by 2-(4-chloro -1-aryl-butylidene) -hydrazinecarbothioamides | |
AU2422999A (en) | New members of the glypican gene family | |
AU1570199A (en) | Methods of lyophilizing solutions | |
AU5568799A (en) | Peptides for inhibition of herpes simplex virus entry | |
AU8842798A (en) | Process for the preparation of ivermectin | |
AU3467197A (en) | Tetracyclical derivatives from pyrimidine | |
AUPP385598A0 (en) | Purification of antibodies | |
AU7987898A (en) | Antigenic modulation of viral particules | |
AU8102498A (en) | Preparation of diaryl-benzopyrans | |
AU4751496A (en) | Herpes simplex virus mutants | |
AUPP561098A0 (en) | Measurement of persistent-latent HIV viral load | |
AU2231499A (en) | Novel vaccine compositions for herpes simplex virus | |
AU2359195A (en) | Viral ribonucleocapsid as an immunological enhancer | |
AU8814398A (en) | Telomerase assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |